T.Man Pharmaceutical PCL (BKK:TMAN)

Thailand flag Thailand · Delayed Price · Currency is THB
11.40
+0.30 (2.70%)
At close: Jun 5, 2025, 4:30 PM ICT
-39.04%
Market Cap 4.44B
Revenue (ttm) 2.24B
Net Income (ttm) 433.10M
Shares Out 400.00M
EPS (ttm) 1.20
PE Ratio 9.26
Forward PE 9.06
Dividend 0.20 (1.80%)
Ex-Dividend Date May 6, 2025
Volume 452,129
Average Volume 436,795
Open 11.00
Previous Close 11.10
Day's Range 11.00 - 11.50
52-Week Range 9.90 - 19.30
Beta n/a
RSI 61.88
Earnings Date May 9, 2025

About T.Man Pharmaceutical PCL

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties’ Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products. The company also provides herbal and ... [Read more]

Sector Healthcare
Founded 1991
Employees 944
Stock Exchange Stock Exchange of Thailand
Ticker Symbol TMAN
Full Company Profile

Financial Performance

In 2024, T.Man Pharmaceutical PCL's revenue was 2.23 billion, an increase of 12.42% compared to the previous year's 1.98 billion. Earnings were 450.70 million, an increase of 4.55%.

Financial Statements

News

There is no news available yet.